For GLP-1 medications, this translates to: Semaglutide Steady state reached after approximately 45 weeks of weekly injections Dulaglutide Steady state reached after approximately 24 weeks Liraglutide Steady state reached after approximately 3 days of daily injections Exenatide extended-release Steady state reached after approximately 67 weeks Short-acting agents (exenatide immediate-release, lixisenatide) Steady state reached within 12 days Once steady state is achieved, the medication concentration remains relatively constant, fluctuating only slightly between doses
Tirzepatide for Weight Loss Blog
Ghule AE, Kulkarni CP, Bodhankar SL, Pandit VA
Fatigue can amplify the perception of discomfort, so prioritising rest is important
Lancet, pp 12231249 Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G (2017) A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population
After 21 days at room temperature, the pen must be used or discarded, even if the expiration date has not passed